Device Trial Radar · NCT03934788
the Clinical Performance of the Oxysoft Daily Disposable Silicone Hydrogel Soft Contact Lens
Last checked: Nov 20, 2026Latest source record: May 2, 2019 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
36
Actual
Start
Sep 26, 2018
Primary completion
Nov 29, 2018
Study completion Nov 29, 2018
Sponsor
- Lead sponsor
- Visco Vision Inc.Not on our public-company list
- Sponsor type
- Industry
- Collaborators
- Jens Medical Consulting Ltd.
- First posted
- May 2, 2019
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, investigator, outcomes assessor)
- Primary purpose
- Supportive care
- FDA-regulated device
- No
- Who can join
- All sexes, from 20 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The objective of this study is to demonstrate that the OxySoft silicone hydrogel soft contact lens could be prescribed as a supportive care for myopes.
Conditions
- Myopia
Interventions
oxysoft (olifilcon C)Device
subjects meet certain criteria will be administered randomly oxysoft on both eye for one month on daily wear single use modality.
Si-Hy (olifilcon B)Device
subjects meet certain criteria will be administered randomly Si-Hy on both eye for one month on daily wear single use modality.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Log MAR visual acuitiesTime frame: 1 month
Locations
3 sites in 1 country. Site status is shown where the registry gives one.
Taipei TzuChi Hopsital, Buddhist Tzu Chi Medical Foundation
New Taipei City, Taiwan
Tri-Service General Hospital_Tingjhou
Taipei, Taiwan
MayKay Memorial Hospital
Taipei, Taiwan
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.